Literature DB >> 19319952

Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa.

Matthew Bates1, Mwaka Monze, Humphrey Bima, Mirriam Kapambwe, David Clark, Francis C Kasolo, Ursula A Gompels.   

Abstract

Human herpesvirus 6, HHV-6, commonly infects children, causing febrile illness and can cause more severe pathology, especially in an immune compromised setting. There are virulence distinctions between variants HHV-6A and B, with evidence for increased severity and neurotropism for HHV-6A. While HHV-6B is the predominant infant infection in USA, Europe and Japan, HHV-6A appears rare. Here HHV-6 prevalence, loads and variant genotypes, in asymptomatic compared to symptomatic infants were investigated from an African region with endemic HIV-1/AIDS. DNA was extracted from blood or sera from asymptomatic infants at 6 and 18 months age in a population-based micronutrient study, and from symptomatic infants hospitalised for febrile disease. DNA was screened by qualitative and quantitative real-time PCR, then genotyped by sequencing at variable loci, U46 (gN) and U47 (gO). HIV-1 serostatus of infants and mothers were also determined. HHV-6 DNA prevalence rose from 15% to 22% (80/371) by 18 months. At 6 months, infants born to HIV-1 positive mothers had lower HHV-6 prevalence (11%, 6/53), but higher HCMV prevalence (25%, 17/67). HHV-6 positive febrile hospitalized infants had higher HIV-1, 57% (4/7), compared to asymptomatic infants, 3% (2/74). HHV-6A was detected exclusively in 86% (48/56) of asymptomatic HHV-6 positive samples genotyped. Co-infections with both strain variants were linked with higher viral loads and found in 13% (7/56) asymptomatic infants and 43% (3/7) HIV-1 positive febrile infants. Overall, the results show HHV-6A as the predominant variant significantly associated with viremic infant-infections in this African population, distinct from other global cohorts, suggesting emergent infections elsewhere. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319952     DOI: 10.1002/jmv.21455

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  36 in total

1.  Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle.

Authors:  Hiroko Oyaizu; Huamin Tang; Megumi Ota; Nobuyuki Takenaka; Keiichi Ozono; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Development of a human herpesvirus 6 species-specific immunoblotting assay.

Authors:  Yuki Higashimoto; Akane Ohta; Yukihiro Nishiyama; Masaru Ihira; Ken Sugata; Yoshizo Asano; Daniel L Peterson; Dharam V Ablashi; Paolo Lusso; Tetsushi Yoshikawa
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

3.  Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants.

Authors:  Soren Gantt; Jackson Orem; Elizabeth M Krantz; Rhoda Ashley Morrow; Stacy Selke; Meei-Li Huang; Joshua T Schiffer; Keith R Jerome; Annet Nakaganda; Anna Wald; Corey Casper; Lawrence Corey
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

Review 4.  Chemokines encoded by herpesviruses.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Leukoc Biol       Date:  2017-08-28       Impact factor: 4.962

5.  Detection frequency of human herpesviruses-6A, -6B, and -7 genomic sequences in central nervous system DNA samples from post-mortem individuals with unspecified encephalopathy.

Authors:  Svetlana Chapenko; Silvija Roga; Sandra Skuja; Santa Rasa; Maksims Cistjakovs; Simons Svirskis; Zane Zaserska; Valerija Groma; Modra Murovska
Journal:  J Neurovirol       Date:  2016-01-04       Impact factor: 2.643

6.  No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome.

Authors:  Peter D Burbelo; Ahmad Bayat; Jason Wagner; Thomas B Nutman; James N Baraniuk; Michael J Iadarola
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

7.  gp96 Is Critical for both Human Herpesvirus 6A (HHV-6A) and HHV-6B Infections.

Authors:  Jingjing Ma; Junli Jia; Xuefeng Jiang; Mengyuan Xu; Jinfeng Guo; Tian Tang; Xianyi Xu; Zhisheng Wu; Benshun Hu; Kun Yao; Lingyun Li; Huamin Tang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 8.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 9.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

10.  Identification of the human herpesvirus 6A gQ1 domain essential for its functional conformation.

Authors:  Takahiro Maeki; Mayuko Hayashi; Akiko Kawabata; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.